GANGAGEN
GangaGen, Inc. is a clinical-stage biotechnology company focused on developing novel therapeutic proteins targeting infectious diseases in areas of high unmet need such as MRSA and other drug resistant bacteria. Using a proprietary platform, GangaGen is developing highly-specific therapeutic proteins called ectolysins to target clinically meaningful types of bacteria. The company’s lead ectolysin, P128, is a recombinant protein that binds to and kills Staphylococcus, including methicillin-resistant strains of S. aureus (MRSA).
GANGAGEN
Social Links:
Industry:
Biotechnology
Founded:
2000-01-01
Address:
Bangalore, Karnataka, India
Country:
India
Website Url:
http://www.gangagen.com
Total Employee:
11+
Status:
Active
Contact:
+1-650-8569642
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Similar Organizations
Avistone Pharmaceuticals
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
ConserV Bioscience
ConserV Bioscience is a clinical-stage biotechnology company focused on developing vaccines.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - GangaGen
Official Site Inspections
http://www.gangagen.com
- Host name: 17.51.180.107.host.secureserver.net
- IP address: 107.180.51.17
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "GangaGen"
About - GangaGen
GangaGen advanced it’s candidate compound into human clinical trials for the decolonization of Methicillin Resistant Staphylococcus aureus from human nares in 2015. GBPL's Beginnings. GBPL was founded and registered in India in …See details»
GangaGen - Crunchbase Company Profile & Funding
GangaGen, Inc. is a clinical-stage biotechnology company focused on developing novel therapeutic proteins targeting infectious diseases in areas of high unmet need such as MRSA …See details»
Management - GangaGen
Prior to joining GangaGen, Ms. Sriram gained extensive experience in chemistry, manufacturing and controls and regulatory requirements for Bio-therapeutics at Dr. Reddy’s Laboratories, …See details»
GangaGen :: Pioneering the battle against drug-resistant bacteria
GangaGen, Inc. was founded in India in 2000 and incorporated in the US in 2001 by Dr. J. Ramachandran, with the aim to develop novel therapies for treating antibiotic-resistant …See details»
GangaGen Company Profile 2024: Valuation, Funding …
GangaGen General Information Description. Developer of engineering novel treatments designed to prevent bacterial infections that are resistant to antibiotics. The company's treatment is a recombinant protein that binds to and kills …See details»
GangaGen Biotechnologies - LinkedIn
GangaGen Biotechnologies | 2,859 followers on LinkedIn. Pioneering the Development of Novel Ectolysins and Bacteriocins against Drug-resistant Bacteria | GangaGen, Inc. is a …See details»
GangaGen, Inc. - VentureRadar
GangaGen is developing ectolysins to treat drug resistant bacteria. GangaGen, Inc. is a clinical-stage biotechnology company focused on developing novel therapeutic proteins targeting …See details»
GangaGen - Funding, Financials, Valuation & Investors - Crunchbase
GangaGen is a clinical-stage biotechnology company focused on developing novel therapeutic proteins. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Gangagen Company Profile - Office Locations, Competitors ... - Craft
Gangagen is a biotechnology company focused on the development of products for the prevention and treatment of bacterial infections. Using a proprietary platform, it provides …See details»
GangaGen Biotechnologies - Devex
GangaGen Biotechnologies Private Limited, India (GBPL), is a biologics company specialized in discovering, designing and developing novel therapies for treating serious bacterial infections.See details»
Board of Directors - GangaGen
GangaGen Biotechnologies Pvt. Ltd., India (GBPL) Dr. T. S. Balganesh President, GBPL and Member, Board of Directors, GBPL View Bio. ... It has grown to be a full-fledged …See details»
GangaGen - Contacts, Employees, Board Members, Advisors
GangaGen is a clinical-stage biotechnology company focused on developing novel therapeutic proteinsSee details»
gangagen.com Reviews: Is this site a scam or legit?
Registrant Name: Jayasheela, Manur Registrant Organization: Gangagen Biotechnologies Pvt Ltd Registrant Street: No 12 5th Cross Raghavendra layout Registrant City: Bangaore Registrant …See details»
Bengaluru firm bags U.S. funding for anti-bacterial research
Oct 5, 2020 GangaGen is developing klebicins, which are naturally occurring protein antibiotics, as precision agents to target K. pneumoniae. Klebicins’ novel mechanism of action enables …See details»
CARB-X is funding GangaGen Biotechnologies to develop a new …
Oct 4, 2020 Multidrug-resistant K. pneumoniae is a leading cause of life-threatening infections, including hospital-acquired and ventilator-associated pneumonia (BOSTON: October 4, 2020) …See details»
GangaGen secures US$2.1 million from CARB-X for lead optimization
Aug 17, 2023 New Delhi: GangaGen has secured the second portion of its phased funding grant from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), the …See details»
GangaGen Biotechnologies - Carb-X
Aug 1, 2020 GangaGen is developing novel antibacterial proteins called klebicins into a narrow-spectrum agent targeting multidrug-resistant K. pneumoniae, including the carbapenem …See details»
Services - GangaGen
GangaGen, with expertise in phage biology offers customized bacteriophage testing services to determine the presence or absence of phage contaminants in E. coli cell banks or production …See details»
News and Events - GangaGen
Oct 4, 2020 Exciting Sports Day at GangaGen. July 28, 2023. GangaGen Celebrates Employee Achievements. June 1, 2023. CARB-X is Funding GangaGen Biotechnologies to Develop a …See details»